Will Neuralink's valuation hit (HIGH) $100B by December 31?
As of July 28, 2026, the market gives “Will Neuralink's valuation hit (HIGH) $100B by December 31?” a 91% chance of NO.
| YES odds | 10% |
|---|---|
| NO odds | 91% |
| Volume | $30,083 |
| Closes | January 1, 2027 |
Updated July 28, 2026 · Live data from Polymarket
About this market
Neuralink’s most recent primary funding round closed in mid-2025 at a post-money valuation near $9.65 billion after raising $650 million, more than doubling the prior $5 billion level from 2023. Secondary-market data as of early June 2026 show shares trading at substantial premiums, with implied valuations exceeding $45 billion amid high trading volume, reflecting investor bets on clinical momentum. The company has expanded human implants, secured FDA Breakthrough Device designations for speech and vision restoration, and advanced trials across multiple countries, supported by investors including ARK Invest, Sequoia, and Founders Fund. Total capital raised now surpasses $1.3 billion, providing runway without an immediate IPO. Key near-term catalysts include further regulatory milestones, additional patient data releases, and any new funding discussions that could reset the official valuation benchmark before year-end.